Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Sezary Syndrome 1 Sarcoma 1 Recurrence 1 Prostatic Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasm Metastasis 1 Mycosis Fungoides 1 Lymphoma, T-Cell, Cutaneous 1 Lung Neoplasms 1 Eczema 1 Dermatitis, Atopic 1 Adenocarcinoma 1

Interventions

Doxorubicin 15 pembrolizumab 12 Surgical Procedures, Operative 8 Cyclophosphamide 8 Blood Specimen Collection 8 Ifosfamide 7 Gemcitabine 7 Surveys and Questionnaires 6 Nivolumab 6 Trabectedin 5 Radiotherapy 5 Magnetic Resonance Spectroscopy 5 Drug Therapy 5 atezolizumab 4 Temozolomide 4 Specimen Handling 4 Radiation Dose Hypofractionation 4 Biopsy 4 pazopanib 3 liposomal doxorubicin 3 fludarabine 3 cabozantinib 3 anlotinib 3 Radiation 3 Observation 3 Docetaxel 3 Dacarbazine 3 trastuzumab deruxtecan 2 toripalimab 2 selinexor 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Sarcoma × Urine Specimen Collection × Clear all

NCT06482957 2025-09-19

CAUSAL

Vanderbilt-Ingram Cancer Center

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡